Brief: Akero Therapeutics To Report Results Of Phase 2B Symmetry Study In October 2023
28/08/2023 12:10
Aug 28 (Reuters) - Akero Therapeutics Inc AKRO.O :
* AKERO THERAPEUTICS TO REPORT RESULTS OF PHASE 2B SYMMETRY
STUDY
IN OCTOBER 2023
Source text for Eikon: ID:nGNX5WCRZB
Further company coverage: AKRO.O
Recent news on Akero Therapeutics
See all newsBrief: Novo Nordisk Completes Acquisition Of Akero Therapeutics
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Germany's Cartel Office Says It Approved Acquisition Of Akero Therapeutics By Novo Nordisk
Brief: Akero Therapeutics Stockholders Approve Acquisition By Novo Nordisk